REVZYP

Serial Number 88814601
606

Registration Progress

Application Filed
Feb 28, 2020
Under Examination
Aug 18, 2020
Approved for Publication
Jun 23, 2020
Published for Opposition
Jun 23, 2020
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: REVZYP
Previous Owner: Opiant Pharmaceuticals, Inc.
Classes: 005

Trademark Image

REVZYP

Basic Information

Serial Number
88814601
Filing Date
February 28, 2020
Published for Opposition
June 23, 2020
Abandonment Date
September 18, 2023
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Sep 18, 2023
Classes
005

Rights Holder

Opiant Pharmaceuticals, Inc.

03
Address
Suite 500
201 Santa Monica Boulevard
Santa Monica, CA 90401

Ownership History

Opiant Pharmaceuticals, Inc.

Original Applicant
03
Santa Monica, CA

Opiant Pharmaceuticals, Inc.

Owner at Publication
03
Santa Monica, CA

Legal Representation

Attorney
Joseph A. Mahoney

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

37 events
Date Code Type Description Documents
Sep 18, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Sep 18, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Mar 9, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 8, 2023 EX5G S SOU EXTENSION 5 GRANTED Loading...
Feb 16, 2023 EXT5 S SOU EXTENSION 5 FILED Loading...
Mar 3, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 16, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 21, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 19, 2022 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jul 19, 2022 EXT4 S SOU EXTENSION 4 FILED Loading...
Jul 19, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 10, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 8, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Feb 8, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Feb 8, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 17, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 15, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 15, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Jul 15, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 6, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
May 6, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 6, 2021 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
May 6, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
May 6, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 6, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jan 29, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 27, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 27, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 27, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 18, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 23, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 23, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 3, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 19, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 19, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 6, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 5, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical products, namely, pharmaceutical preparations for treating opioid overdoses; Pharmaceutical preparation, namely, an opioid antagonist

Classification

International Classes
005